Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us nowMarket share of global diabetes care devices manufacturers 2011
This statistic depicts the market share of the global top diabetes care devices manufacturers in 2011. In that year, Medtronic from the United States had a 7.5 percent share in the total global market for diabetes care devices.
Top diabetes care devices manufacturers
Diabetes is one of the leading causes of death in the United States. In 2010, 20.8 people per 100,000 of the U.S. population died due to diabetes. In the United States, 239 billion U.S. dollars was expended in 2013 to treat diabetes. However, in China, a country with one of the largest number of diabetics in the world, only 38 billion U.S. dollars was spent on diabetes health care. The diabetes care market is expected to grow to almost 16 billion U.S. dollars in the United States by 2017.
In 2011, F.Hoffman-La Roche Ltd and LifeScan, Inc. together are considered a large part of the top diabetes care device manufacturers in the world at 15.2 percent and 14.2 percent of the global market share, respectively. Lifescan is part of the Johnson & Johnson Company and has developed glucose monitoring devices such as OneTouch Ultra for home and hospital use. About 61 percent of global diabetes care devices can be listed under the glucose monitoring device category and 24 percent under insulin delivery devices. Insulin pump therapy has vastly improved since the 1970s, with alarms for malfunction and wireless connection to meters and computers. This type of device is a widely used product for diabetics around the world.
Top diabetes care devices manufacturers
Diabetes is one of the leading causes of death in the United States. In 2010, 20.8 people per 100,000 of the U.S. population died due to diabetes. In the United States, 239 billion U.S. dollars was expended in 2013 to treat diabetes. However, in China, a country with one of the largest number of diabetics in the world, only 38 billion U.S. dollars was spent on diabetes health care. The diabetes care market is expected to grow to almost 16 billion U.S. dollars in the United States by 2017.
In 2011, F.Hoffman-La Roche Ltd and LifeScan, Inc. together are considered a large part of the top diabetes care device manufacturers in the world at 15.2 percent and 14.2 percent of the global market share, respectively. Lifescan is part of the Johnson & Johnson Company and has developed glucose monitoring devices such as OneTouch Ultra for home and hospital use. About 61 percent of global diabetes care devices can be listed under the glucose monitoring device category and 24 percent under insulin delivery devices. Insulin pump therapy has vastly improved since the 1970s, with alarms for malfunction and wireless connection to meters and computers. This type of device is a widely used product for diabetics around the world.
